Skip to main content
Have a personal or library account? Click to login
The effect of orthodontic appliances on the Oral Candida colonisation: a systematic review Cover

The effect of orthodontic appliances on the Oral Candida colonisation: a systematic review

Open Access
|Mar 2022

Figures & Tables

Figure 1

Flow diagram of the included studies according to the PRISMA.

Characteristics of the studies_

No.Study ID/DesignPatients (M/F)AgeaApplianceSample siteTimingAnalysis methodOutcomeAdditional measuresQuality of the study
1Arendorf 198513ProspectiveExp: 33 (15/18)8–17 yROASix mucosal site (ant and post palate, ant and post tongue, r and l cheek)T0 = before AppInsT1 = during therapyT2 = after AppRem (after average 9 mos)Imprint Culture (Arendorf and Walker technique)Prevalence (%) DensityPI + saliv pHC
2Hägg 200414ProspectiveExp: 27 (13/14)15.5 + 2.3 yFOARinse Dorsum of the tongue Supra and subgingival plaqueT0=before AppInsT1 = 1 mos after T0T2 = 2 mos after T0T3 = 3 mos after T0Oral Rinse (Samaranayake technique) Imprint Culture (Arendorf and Walker technique) (SDA, Gram stain, germ tube test, API 20 C AUX) Pooled PlaquePrevalence (%)Density (CFU)Species compositionPI + count of Enterobacteriaceae + total bacterial countB
3Arslan 200815ProspectiveExp 1: 72Exp 2: 42 (19/23) Candida carriers out of 72 subjects, that were treated19.8 yFOA (metal brackets)Dorsum of the tongue (only for T0)Mid-palate (only for T0)SalivaU5/L5U1/L1T0 = before AppInsT1 = 1 mos after T0T2 = 6 mos after T0T3 = 12 mos after T0Swab Culture (Kleinegger method, SDA)Salivary culture (SDA, Gram staining, germ-tube test, chlamydospore, API 20C AUX system))Pooled plaque (SDA)Prevalence (%)Density (CFU)Species compositionNoneB
4Lee 200816ProspectiveExp: 97 (38/59)17.7 yFOARinseFrom T0 = before AppIns to T10 = 12 mos after T0Oral rinse technique (Samaranayake technique, SDA)Phenotypic methods (germ-tube test; API ID 32C)Genotypic methods (RAPD analysis)Dendogram analysisPrevalence (%)Species compositionNoneC
5Mahmoudadabi 200917ProspectiveExp 1: 34Exp 2: 3413 y (Exp 1)12.5 y (Exp 2)ROA (upper) CrSaliva Surface of upper appliance (not considered)T0 = before AppInsT1 = over 8 mos after T0Culture (Arendorf and Walker, Davenport techiques) (CHROMagar; germ-tube test)Prevalence (%)Count (CFU)Species compositionNoneC
6Gonçalves e Silva 201418ProspectiveExp 1: 30Exp 2: 309.1+−1.7 (Exp 1)7.7+−1.5 (Exp 2)ROA CrCheek and lateral surface of the tongue SalivaT0 = before AppInsT1 = at least 6 mos after T0Culture (SDA; CHROMagar) Phenotypic methods Exfoliative cytologyPrevalence (%)Count (CFU)Species compositionCounts of Anti-C.albicansIgAB
7Arab 20168ProspectiveExp 1: 30 (6/24)12–18 yFOASalivaT0 = before AppInsT1 = 6 we after T0T2 = 12 we after T0T3 = 18 we after T0Culture (SDA)Count (CFU)Salivary flow and pH Microbial counts (S. mutans/L. acidophilus)C
8Khanpayeh 201419ProspectiveExp 1: 40Exp 2: 40 (35/45)7–18 yFOA (metal) ROAUnstimulated salivaT0 = before AppInsT1 = 6 mos after T0Culture (SDA; Germ-tube test; corn meal agar)Biochemical tests (API 20C method)Frequency (%)Species compositionNoneB
9Kundu 201620ProspectiveExp 1: 10Exp 2: 10 (not considered)6–15 yROA Fixed space maintainers (nc)Unstimulated salivaT0 = before AppInsT1 = 1 mo after T0T2 = 3 mos after T0T3 = 6 mos after T0Culture (SDA)Count (CFU)Bacterial count (S. mutans and Lactobacillussp.)B
10Zheng 201621ProspectiveExp 1: 50 (23/27)10–18 (13.6 y)FOAGargleT0 = before AppInsT1 = 1 mo after T0T2 = 2 mos after T0T3 = 3 mos after T0T4 = 6 mos after T0Culture (CHROMagar)PCR (Tiangen Biotech)Incidence (%)Count (CFU)Species compositionNoneB
11Shukla 201722ProspectiveExp 1: 6016–18 yFOABuccal and labial Plaque of anterior teeth and U6 + L6T0 = before AppInsT1 = 2 mo after T0T2 = 3 mos after T0Swab Culture (SDA; Gram stain; germ tube test, counts in CFU)Count (CFU)S. mutansB
12Grzegocka 202023ProspectiveExp 1: 17 (6M/11)17+−7 yFOAOral rinse Elastomeric rings (nc)T0 = before AppInsT1 = 2 we after T0T2 = 6 we after T0T3 = 12 we after T0Culture (Dalmau plate technique)Biochemical tests (API 20C AUX)Prevalence (%)Count(CFU) Species compositionAPIGBIBiofilm formationC
13Sanz-Orrio-Soler 202024Prospective Controlled TrialExp 1: 124 (43/80)19.5 yFOA (metal or ceramic)U and L vestibuleT0 = before AppInsT1 = 1 mo after T0T2 = 6 mos after T0T3 = 12 mos after T0T4 = 6 mos afterSwab Culture (CHROMagar plates, Becton Dickinson)Frequency (%)Species compositionQuestionnaire about hygiene habitsB
14Pellissari 202125ProspectiveExp 1: 23 (7/10)Exp 2: 6 (2/4)20.7+− 8.7 y (Exp 1)19.6+−1.3 y (Exp 2)FOACrBiofilm around bckFrom 3 to 6 mos after AppInsCulture Biochemical tests (VITEK 2 compact system)Prevalence (%)Species compositionFungal strains and resistance to Antifungals Bacterial strains and resistance to AntimicrobialsB
15Rodríguez Rentería 202126ProspectiveExp 1: 55 (34/21)8.4 yROASupport oral mucosa Surface of ROA (not considered)T0 = before AppInsT1 = 4 we after T0Chromogenic culture (ID 32 C AUX system)Frequency (%)Species compositionMicrobial species (Str.aureus, P.aeruginosa)C
16Kouvelis 202127ProspectiveExp 1: 30 (17/13)13.97 +− 2.07FOASalivaT0 = before AppInsT1 = 4 we after T0T1 = 12 we after T0CultureCountSalivary pH, flow rate, buffering capacityOther microbial speciesC

List of inclusion and exclusion criteria_

FieldInclusionExclusion
PatientsChildren, adolescents or young adults (<25 years) of any sex, ethnicity and malocclusion, in general good healthAdults (>25 years)In vitro studiesAnimal studies
Intervention (exposure)Orthodontic treatment with any vestibular fixed appliance (metal or ceramic, conventionally-ligated or self-ligated) or any removable appliancesPatients not receiving orthodontic treatmentPatients receiving orthodontic treatment without specific descriptions of the materials and applied techniquePatients receiving partial appliancesPatients receiving or having received systemic antibiotic treatment less than a month before or during orthodontic treatmentSmoking patients
ComparisonA. No comparison (For the descriptive analysis of Candida changes in treated patients)B. Ortho-tx vs no-tx (Comparison between treated and non treated patients)C. Ortho-tx vs ortho-tx (Comparison between ROA and FOA)
OutcomeQuantitative and qualitative analysis of Candida colonies, from intra-oral mucosal sites, saliva or supra/sub-gingival plaque.All available time-points will be included and categorized into pre-treatment, short-term (< 3 months) treatment, mid-term (3–6 months) treatment and long-term (< 6 months) treatment, post-treatmentNo clear mention of the analysis or time-point
Study designRandomized clinical trials or non-randomized, prospective or retrospective, cohort studies

Swedish council on technology assessment in health-care (SBU) criteria for grading assessed studies_

SBU criteria for grading assessed studies
Grade A (High level of evidence)Randomized clinical study or prospective study with a well-defined control group, defined diagnosis and endpoints, diagnostic reliability tests and reproducibility tests described
Grade B (Moderate level of evidence)Cohort study or retrospective case series with defined control or reference group, defined diagnosis and endpoints, diagnostic reliability tests and reproducibility tests described
Grade C (Low level of evidence)Large attrition, unclear diagnosis and endpoints, poorly defined patient material

Definitions of evidence level_

LevelEvidenceDefinition
1StrongAt least two studies assessed with level “A”
2ModerateOne study with level “A” and at least two studies with level “B”
3LimitedAt least two studies with level “B”
4InconclusiveFewer than two studies with level “B”
DOI: https://doi.org/10.2478/aoj-2022-0006 | Journal eISSN: 2207-7480 | Journal ISSN: 2207-7472
Language: English
Page range: 51 - 62
Submitted on: Nov 1, 2021
Accepted on: Jan 1, 2022
Published on: Mar 14, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Alessandra Campobasso, Eleonora Lo Muzio, Giovanni Battista, Vito Carlo Alberto Caponio, Domenico Ciavarella, Lorenzo Lo Muzio, published by Australian Society of Orthodontists Inc.
This work is licensed under the Creative Commons Attribution 4.0 License.